Clinical Trials Browser

Phase 1 × Neoplasm, Residual × niraparib × Clear all

NCT03945721 2025-09-29

UNITY

Phase 1 Active not recruiting

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms